You are here

  • Home
  • Archive
  • Volume 81, Issue 12
  • Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhang et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhang et al
Free

Authors

  1. Correspondence to Dr Tae-Hwan Kim, Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seongdong-gu 04763, Republic of Korea; thkim{at}hanyang.ac.kr
View Full Text

Citation

Koo BS, Oh JS, park SY, et al
Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhang et al
Annals of the Rheumatic Diseases 2022;81:e253.

Publication history

  • Received September 9, 2020
  • Accepted September 10, 2020
  • First published October 1, 2020.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.